Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
16-30 of 1762 results
IBM Watson, Broad Institute partner on $50m cancer drug resistance project
By PBR Staff Writer
IBM and the Broad Institute of MIT and Harvard have launched a five-year, $50m research initiative to study why cancers become drug resistant.
Automation > IT & Software > News
DNAtrix licenses Myxoma virus for new immunotherapy platform
DNAtrix, a privately held, clinical stage, biotechnology firm developing virus-driven immunotherapies for cancer, has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
Automation > IT & Software > News
UK artificial intelligence firm secures rights to several Janssen drug candidates
UK artificial intelligence (AI) firm BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Automation > IT & Software > News
ERS Genomics agrees to license CRISPR/Cas9 to Knudra Transgenics
ERS Genomics and Knudra Transgenics have signed a non-exclusive license agreement on CRISPR-Cas9 genome editing patents for model organisms.
Automation > IT & Software > News
Teva, IBM to develop cognitive technologies for drug repurposing
By PBR Staff Writer
Teva Pharmaceutical Industries and IBM have expanded their worldwide e-health alliance with new projects designed to discover new uses for existing drugs and advance chronic disease management.
Automation > IT & Software > News
IBM makes Watson technology available to US employees fighting cancer
IBM is offering its Watson technology to its US employees to help them identify appropriate cancer treatments and options for clinical trials.
Automation > IT & Software > News
Nexus BioPharma signs deal with TransChem for kinase inhibition technology
Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition.
Automation > IT & Software > News
Codexis completes final phase in transfer of CodeEvolver technology to Merck
Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a non-exclusive licensing agreement.
Automation > IT & Software > News
Bayer, DelSiTech partner to develop new drug delivery technology for ophthalmology
Bayer and DelSiTech have partnered to develop innovative drug delivery technology for ophthalmology.
Automation > IT & Software > News
AstraZeneca selects LLamasoft as supply chain design technology partner
AstraZeneca has selected LLamasoft’s Supply Chain Guru and Data Guru as tools of choice for supply chain modelling.
Automation > IT & Software > News
Ligand Pharmaceuticals signs OmniAb license deal with TeneoBio
Ligand Pharmaceuticals has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio.
Automation > IT & Software > News
Pfizer launches app to help patients manage depression
Pfizer has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression.
Automation > IT & Software > News
EPAM, Sinequa partner to address cognitive search & analytics challenges in pharma industry
EPAM Systems and Sinequa have partnered to deliver search and analytics solutions for data-driven Global 2000 companies in the pharmaceutical industry.
Automation > IT & Software > News
Merck introduces new gene editing technology to modify CHO cell lines
Merck has introduced a gene editing technology that can modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.
Automation > IT & Software > News
Compugen enhances LINKS computational platform
Compugen disclosed that its LINKS computational platform, initially designed for the characterization and differentiation of existing novel drug target candidates, has been enhanced to include the in silico discovery of new immuno-oncology drug targets, with a specific focus on the discovery of myeloid targets within the tumor microenvironment (TME).
Automation > IT & Software > News
16-30 of 1762 results